Astute Medical, a US-based provider of laboratory tests, has extended its series B round by $13m to its existing investment consortium that includes Johnson & Jonson’s corporate venturing unit.
Alongside Johnson & Johnson Development Corporation in the B extension are venture capital firms Domain Associates, Delphi Ventures and De Novo Ventures.
Astute had initially raised $26.5m in its B round in May.
Founded in 2007 by Christopher Hibberd and Paul McPherson, former managers at diagnostics company Biosite before its acquisition by Inverness Medical Innovations for $1.7bn earlier that year, Astutue had raised $6.2m in it’s A round in May 2008.